MMP2 and neoplasm: To conclude, FRET-based activatable imaging agents for the tumor-specific enzymes MMP-2/9 not only show potential for activatable luminescence imaging, in combination with Ir(ppy)3, this concept can now even be extended to the field of (microscopic) luminescence lifetime imaging.